Announced Mon, 22 Sept · 16:41 IST

Proceedings of the 14th Annual General Meeting of the Company.

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Fabino Enterprises Ltd (formerly Fabino Life Sciences Limited) held its 14th AGM on September 22, 2025, at its registered office in Sonipat, Haryana. The meeting was chaired by Managing Director Mr. Aditya Mahavir Jain and attended by 6 members. Four resolutions were passed — three ordinary and one special — including adoption of the standalone and consolidated financial statements for FY 2024-25, re-appointment of Mr. Arihant Jain as director (retiring by rotation), and regularization of Mrs. Vandana Jain as Executive Director. The Statutory and Secretarial Auditors' reports for FY ended March 31, 2025 contained no qualifications or adverse observations. Remote e-voting was open from September 18 to 21, 2025, and ballot voting was also made available at the venue, with results to be declared within 2 working days.

Likely market impact

This is a routine, procedural AGM filing with no major surprises. The clean (unqualified) audit reports are a positive signal, and the director changes are standard governance items. No immediate material impact on shareholders or stock price is expected.